ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study to Evaluate the Relative Bioavailability of Two Risankizumab Drug Product Presentations in Healthy Volunteers.

AbbVie · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
healthy volunteers, risankizumab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 810190
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.